Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: laboratory criteria for the diagnosis and control of treatment efficacy
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 5
Abstract
Non-classic congenital adrenal hyperplasia (NCAH) due to 21-hydroxylase deficiency is one of the actual causes of hyperandrogenic manifestations at different age intervals. Timely diagnosis of the disease requires evaluating basal 17-hydroxyprogesterone levels during the comprehensive examination of patients of different age groups with clinical manifestations of androgen excess. This is especially important when examining adolescent girls and women of reproductive age with signs of hyperandrogenism. The obligatory examination of women when establishing the diagnosis of polycystic ovary syndrome should include the exclusion of non-classical NCAH according to all world recommendations. When 17-hydroxyprogesterone levels are in the range of 2–10 ng/ml, it is necessary to carry out cosyntropin stimulation test, which is recognized worldwide as the standard of NCAH diagnosis. The diagnostic threshold for NCAH diagnosis due to 21-hydroxylase deficiency is a level of 17-hydroxyprogesterone, basal or stimulated in cosyntropin test, higher than 10 ng/ml. Genetic testing — determining mutations in the CYP21A2 gene — is an important and necessary tool not only to confirm the diagnosis, but also to identify treatment of the patient with the diagnosis of NCAH and to determine the risk of emergence of a classic form in an unborn child in the presence of allele associated with classic САН. The recent recommendations from 2018 Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline are taken as the basis of the laboratory diagnostic criteria.
Authors and Affiliations
O. V. Rykova
Keywords
Related Articles
- EP ID EP660859
- DOI 10.22141/2224-0721.15.5.2019.180044
- Views 51
- Downloads 0
Peculiarities of Lipid Metabolism in Patients with Prolactinomas during Suppressive Dopamine Agonist Therapy
The article presents the data of lipid metabolism at the stages of long-term (12 months) suppressive therapy with dopamine agonist cabergoline in 61 patients with prolactinoma. It is proved that the normalization of prol...
Profile of Cardiovascular Risk Factors in Ischemic Heart Disease in Patients with Normal and Impaired Carbohydrate Metabolism
Aim of investigation — to conduct the comparative analysis of profile of general population cardiovascular risk factors in patients with ischemic heart disease (IHD) on a background of normal and impaired carbohydrate m...
Features of Oxidative Stress Formation in Patients with Type 2 Diabetes Mellitus Depending on the Disease Duration and Gender
Background. The incidence of type 2 diabetes is increasing in Ukraine and worldwide. The severity of this disease is determined by the number of complications, with lipid peroxidation (LPO) underlying. The aim of the stu...
Population Risk Factors in the Genesis of Bone Metabolism Didorders in Patients with Autoimmune Thyroiditis
The paper presents population risk factors involved in the genesis of bone metabolism disorders in patients with autoimmune thyroiditis (AIT). The results of the study of bone mineral density in patients with AIT are pro...
Epidemiology and Morphological Features of Thyroid Cancer in People Living in Vinnytsia Region
Background. Thyroid cancer (TC) is the most common tumor of the endocrine glands. The problem of thyroid cancer in Ukraine went far beyond the consequences of the Chernobyl disaster and is characterized by increasing mor...